Evidence map›Paper›PMID 38500964›Full record

ArticleLancet regional health. Americas2024

Prison as a driver of recent transmissions of multidrug-resistant tuberculosis in Callao, Peru: a cross-sectional study.

Christian Utpatel, Milagros Zavaleta, Daniel Rojas-Bolivar, Andreas Mühlbach, Janet Picoy, Walter Portugal, Ana Esteve-Solé, Laia Alsina, Paolo Miotto, Daniella C Bartholomeu and 5 more

Open access · goldAbstract read
In one paragraph

Article in Lancet regional health. Americas, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 3 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 6 countries.

Christian UtpatelMolecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany.
Milagros ZavaletaCentro de Investigaciones Tecnológicas, Biomedicas y Medioambientales, Callao, Peru.
Daniel Rojas-BolivarCentro de Investigaciones Tecnológicas, Biomedicas y Medioambientales, Callao, Peru.
Andreas MühlbachCentro de Investigaciones Tecnológicas, Biomedicas y Medioambientales, Callao, Peru.
Janet PicoyDireccion Regional de Salud del Callao, Callao, Peru.
Walter PortugalDireccion Regional de Salud del Callao, Callao, Peru.
Ana Esteve-SoléAllergy and Clinical Immunology Department, Hospital Sant Joan de Déu Institut de Recerca Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain.
Laia AlsinaAllergy and Clinical Immunology Department, Hospital Sant Joan de Déu Institut de Recerca Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain.
Paolo MiottoEmerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Daniella C BartholomeuInstituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Minas Gerais, Brazil.
Jorge SanchezCentro de Investigaciones Tecnológicas, Biomedicas y Medioambientales, Callao, Peru.
Diego F CuadrosDepartment of Geography and GIS, Health Geography and Disease Modeling Laboratory, University of Cincinnati, Cincinnati, USA.
Jorge O AlarconCentro de Investigaciones Tecnológicas, Biomedicas y Medioambientales, Callao, Peru.
Stefan NiemannMolecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany.
Moises A HuamanCentro de Investigaciones Tecnológicas, Biomedicas y Medioambientales, Callao, Peru.
Dirección Regional de Salud del Callao · PEHospital Sant Joan de Déu Barcelona · ESUniversity of Cincinnati · USGerman Center for Infection Research · DENational University of San Marcos · PEResearch Center Borstel - Leibniz Lung Center · DEUniversidade Federal de Minas Gerais · BRVita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: We sought to identify resistance patterns and key drivers of recent multidrug-resistant tuberculosis (MDR-TB) transmission in a TB-prevalent area in Peru. Methods: Cross-sectional study including MDR Findings: 171 unique MDR-Mtbc strains were included; 22 (13%) had additional fluoroquinolone resistance and were classified as pre-XDR. Six strains (3.5%) harboured bedaquiline (BDQ) resistance mutations and were classified as MDR + BDQ. 158 (92%) Mtbc strains belonged to lineage 4 and 13 (8%) to lineage 2. Using a cluster threshold of ≤5 SNPs, 98 (57%) strains were grouped in one of the 17 D5 clusters indicative of recent transmission, ranging in size from 2 to the largest cluster formed by 53 4.3.3 strains (group_1). Lineage 4.3.3 strains showed the overall highest cluster rate (43%). In multivariate analyses, current or previous imprisonment was independently associated with being part of any MDR-TB transmission clusters (adjusted prevalence ratio [aPR], 1.45; 95% CI, 1.09-1.92). Interpretation: Pre-XDR-TB emerged in more than 10% of the MDR-TB strains investigated. Transmission of 4.3.3 Mtbc strains especially of the dominant group_1 clone is a major driver of the MDR-TB epidemic in Callao. Current or previous imprisonment was linked to recent MDR-TB transmissions, indicating an important role of prisons in driving the MDR-TB epidemic. Funding: This work was supported in part by the ERANet-LAC Network of the European Union, Latin America and the Caribbean Countries on Joint Innovation and Research Activities, and FONDECYT. Additional support was received from Leibniz Science Campus Evolutionary Medicine of the Lung, the Deutsche Forschungsgemeinschaft (German Research Foundation, under Germany's Excellence Strategy-EXC 2167 Precision Medicine in Inflammation), and the Research Training Group 2501 TransEvo.

Indexed as

Genome sequencingMultidrug resistancePrisonTuberculosis

Identifiers

PMID38500964
PMCPMC10945431
OpenAlexW4391071458

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.